Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
04/2002
04/18/2002DE10117815A1 Neue für das cobW-Gen kodierende Nukleotidsequenzen New coding for the cobW gene nucleotide sequences
04/18/2002DE10050942A1 Detecting cytosine methylation in genomic DNA, useful e.g. for disease diagnosis and prognosis, comprises conversion of unmethylated cytosine to uracil then amplification
04/18/2002DE10049267A1 Verfahren zur Erzeugung oder Erhöhung einer Resistenz in Organismen gegenüber biotischen oder abiotischen Streßfaktoren A method for generating or increasing a resistance in organisms to biotic or abiotic stresses
04/18/2002DE10049211A1 Thermostabile Polymerase aus Thermococcus pacificus Thermostable polymerase from Thermococcus pacificus
04/18/2002DE10049074A1 Verfahren zur Selektion hochaffin an ein Target bindender Nukleinsäuren A method for selecting high affinity to a target nucleic acids binding
04/18/2002DE10049010A1 Transferrin-Polykation/DNS-Komplexe für die systemische Therapie von Tumorerkrankungen mit zytotoxischen Proteinen Transferrin-polycation / DNA complexes for systemic therapy of tumors with cytotoxic proteins
04/18/2002DE10048633A1 Methode zur in vitro Diagnostik von Endometriose Method for in vitro diagnosis of endometriosis
04/18/2002DE10047217A1 Verfahren zur Herstellung von Ribonukleinsäure (RNS) A process for the production of ribonucleic acid (RNA)
04/18/2002DE10046913A1 Expressionssystem für funktionale Nukleinsäuren Expression system for functional nucleic acids
04/18/2002DE10044384A1 Wirtszellen zur Verpackung von rekombinantem Adeno-assoziiertem Virus (rAAV), Verfahren zu ihrer Herstellung und deren Verwendung Host cells for the packaging of recombinant adeno-associated virus (rAAV), processes for their preparation and their use
04/18/2002DE10021678A1 Recombinant polyspecific antibody constructs, useful for diagnosis and treatment of cancer, comprises three antibody fragments,where at least one comprises a disulfide bridge
04/18/2002CA2811096A1 Enhanced selection of genetically modified pine embryogenic tissue
04/18/2002CA2785941A1 Antibody composition-producing cell
04/18/2002CA2705037A1 Method for pine cell tissue culture on support membrane
04/18/2002CA2462758A1 Diagnostic indicator of thymic function
04/18/2002CA2462073A1 Hematopoietic stem cell gene therapy
04/18/2002CA2461990A1 Method and apparatus for the in-situ preparation of macromolecules via uniform glow discharge plasma
04/18/2002CA2426753A1 Mammalian wnt polypeptide-5
04/18/2002CA2425917A1 Artificial transcriptional factors and methods of use
04/18/2002CA2425885A1 Cloning and sequencing of the porcine interleukin-12 receptor beta-1 and beta-2 chains
04/18/2002CA2425835A1 Methods and compositions for nucleic acid delivery
04/18/2002CA2425833A1 Egf motif protein, egfl6 materials and methods
04/18/2002CA2425818A1 Novel human beta2 integrin alpha subunit
04/18/2002CA2425815A1 Treatment of t cell disorders
04/18/2002CA2425809A1 Humanized anti-lt-.beta.-r antibodies
04/18/2002CA2425779A1 Compositions that inhibit proliferation of cancer cells
04/18/2002CA2425767A1 Lipocalins
04/18/2002CA2425689A1 Method for modifying a protein structure
04/18/2002CA2425671A1 Human ect2 and methods of use
04/18/2002CA2425643A1 Cancer-linked genes as targets for chemotherapy
04/18/2002CA2425581A1 Modulation of ligand binding/enzymatic activity of alpha beta proteins
04/18/2002CA2425569A1 Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
04/18/2002CA2425545A1 Methods of identification and isolation of polynucleotides containing nucleic acid differences
04/18/2002CA2425515A1 Human ion channel protein and polynucleotides encoding the same
04/18/2002CA2425488A1 Interactive correlation of compound information and genomic information
04/18/2002CA2425366A1 Method for the detection of cytosine methylations
04/18/2002CA2425356A1 Hedgehog antagonists, methods and uses related thereto
04/18/2002CA2425318A1 Far red shifted fluorescent proteins
04/18/2002CA2425302A1 Novel polypeptides homologous to thymosin, ephrin a, receptors, and fibromodulin, and polynucleotides encoding same
04/18/2002CA2425298A1 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof
04/18/2002CA2425293A1 A novel system for the evaluation of the activity and/or specificity of a viral component
04/18/2002CA2425194A1 Modulating cytokine or hormone signalling in an animal comprising up-regulating the expression of socs sequence in the animal
04/18/2002CA2425001A1 Novel serine protease genes related to dppiv
04/18/2002CA2424992A1 Paramyxovirus vectors for introducing foreign genes into skeletal muscle
04/18/2002CA2424983A1 Nucleic acid molecules and polypeptides for immune modulation
04/18/2002CA2424967A1 Complexes for transferring nucleic acids into cells
04/18/2002CA2424946A1 Non typeable haemophilus influenzae basb201 polypeptides and encoding polynucleotides and uses thereof
04/18/2002CA2424938A1 Basb205 polypeptides and polynucleotides encoding therefor
04/18/2002CA2424901A1 Genetic control of sex ratio in animal populations
04/18/2002CA2424856A1 Specific double-stranded probes for homogeneous detection of nucleic acid and their application methods
04/18/2002CA2424821A1 Gene encoding a human g-protein coupled receptor and its use
04/18/2002CA2424435A1 Dendritically amplified detection method
04/18/2002CA2424434A1 Subtilase variants
04/18/2002CA2424433A1 Bvh-a2 and bvh-a3 antigens of group b streptococcus
04/18/2002CA2424379A1 Inhibition of complement c5 activation for the treatment and prevention of delayed xenograft or acute vascular rejection
04/18/2002CA2424323A1 Method for circularizing adenoviral nucleic acid via homologous recombination
04/18/2002CA2424317A1 Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products
04/18/2002CA2424295A1 Metal binding proteins, recombinant host cells and methods
04/18/2002CA2423552A1 High throughput processing system and method of using
04/18/2002CA2422934A1 Antisense oligonucleotides directed toward mammalian vegf receptor genes and uses thereof
04/18/2002CA2422881A1 Human anti-epidermal growth factor receptor single-chain antibodies
04/18/2002CA2422760A1 Improved method for the biosynthesis of vitamin e
04/18/2002CA2393680A1 A schizophrenic model animal with sensorimotor and behavioral abnormalities and a method for preparing the same
04/18/2002CA2393374A1 High throughput or capillary-based screening for a bioactivity or biomolecule
04/17/2002EP1197568A2 Detection and typing of HCV using 5'UTR and NS5 nucleic acid sequences
04/17/2002EP1197567A2 Characterisation of gene function using double stranded RNA inhibition
04/17/2002EP1197563A1 Method for Producing Amino Acids
04/17/2002EP1197558A2 Theobromine synthase polypeptide of coffee plant and the gene encoding said polypeptide
04/17/2002EP1197557A1 Gene encoding cyclic lipopeptide acylase and expression of the same
04/17/2002EP1197556A1 Useful polypeptide
04/17/2002EP1197555A1 Dna encoding sucrose pts enzyme ii
04/17/2002EP1197554A1 Proliferation differentiation factor
04/17/2002EP1197553A1 Antisense nucleic acid against alphaV integrin
04/17/2002EP1197552A2 Method of preparing normalized and/or subtracted cDNA
04/17/2002EP1197550A2 Methods and compositions for diagnosing and treating disorders involving angiogenesis
04/17/2002EP1197549A2 Method for cloning and producing the MseI restriction endonuclease
04/17/2002EP1197496A1 Novel peptides
04/17/2002EP1197220A2 Therapeutic methods and compositions based on delta proteins and nucleic acids
04/17/2002EP1197144A1 Transgenic mice and overexpression model of the gene ntrk3 (trkc) based thereon for the study and monitoring of treatments of anxiety, depression and related psychiatric diseases
04/17/2002EP1197143A1 Goodpasture's syndrome model mouse
04/17/2002EP1197139A1 Construction of rice tolerant to iron deficiency
04/17/2002EP1196779A1 Determining antibodies to ny-eso-1 in cancer patients
04/17/2002EP1196772A2 Induction of a th1-like response in vitro
04/17/2002EP1196755A1 Genetic assay system
04/17/2002EP1196640A2 Electron-deficient nitrogen heterocycle-substituted fluorescein dyes
04/17/2002EP1196639A2 A method for amplifying low abundance nucleic acid sequences and means for performing said method
04/17/2002EP1196638A1 USE OF THE i KRIT1 /i GENE IN ANGIOGENESIS
04/17/2002EP1196637A1 Peptide acceptor ligation methods
04/17/2002EP1196635A2 Cell death related drug targets in yeast and fungi
04/17/2002EP1196634A1 Method for identifying a compound that modulates the function of the gene product of an essential gene
04/17/2002EP1196632A2 Multiple tag analysis
04/17/2002EP1196629A2 High resolution dna detection methods and devices
04/17/2002EP1196628A2 Method and sample support system for separating and processing substances in situ
04/17/2002EP1196617A2 Method for introducing a substance into a cell
04/17/2002EP1196616A2 Replication-competent anti-cancer vectors
04/17/2002EP1196615A2 Methods, compositions and genetic sequences for modulating flowering in plants, and plants genetically modified to flower farly and tardily
04/17/2002EP1196614A1 Plant multi-gene expression constructs
04/17/2002EP1196613A1 Novel vectors for improving cloning and expression in low copy number plasmids
04/17/2002EP1196612A2 Dna binding protein and sequence as insulators having specific enhancer blocking activity for regulation of gene expression
04/17/2002EP1196611A1 Regulation of carbon assimilation